Fresenius - Healthcare Group Back on Growth Track Thanks to Strong Development in Core Business and Cost Reduction Measures!

Business drivers: The healthcare group Fresenius has recently suffered significantly from the impacts of the Corona pandemic and subsequently declining patient numbers. Particularly, the hospital subsidiary Helios was heavily affected. In the meantime, Fresenius has successfully consolidated itself, thanks in part to the sale of peripheral areas such as the divestment of its majority stake in the service subsidiary Vamed and consistently implemented cost-cutting measures. As the company has performed significantly better in key segments like the...